DNA RNA and Cells

07 Aug 2009 Opexa Announces Stem Cell Agreement with Leading Global Pharmaceutical Company
06 Aug 2009 ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program
06 Aug 2009 Alnylam and Tekmira Participate in New Research Collaboration
05 Aug 2009 Aldagen Reaches Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3 Trial of ALD-301 for Critical Limb Ischemia
05 Aug 2009 PROPRIETARY TECHNOLOGY IN WORLD-FIRST ALLOGENEIC STEM CELL TRIAL FOR TREATMENT OF END-STAGE HEART FAILURE IN PATIENTS SUPPORTED BY MECHANICAL HEART ASSIST DEVICES
03 Aug 2009 MDRNA, Inc. Reports Positive In Vivo Data Demonstrating That Its UsiRNAs Are Highly Potent Against Metabolic and Oncology Targets
30 Jul 2009 ReNeuron receives UK ethics committee Favourable Opinion for stroke clinical trial
27 Jul 2009 RXi Pharmaceuticals Acquires Exclusive License to Proprietary, Potentially Paradigm-Changing RNAi Delivery Technology from Advirna LLC
27 Jul 2009 Quark Pharmaceuticals Announces Data Indicating Potential Utility of QPI-1007 for Treatment of Glaucoma
27 Jul 2009 MOLOGEN AG extends clinical study to include another dosing group
23 Jul 2009 miRagen and Archemix to Collaborate on Conjugated Aptamer-microRNA Therapeutics
21 Jul 2009 Archemix and Dicerna to Collaborate on Conjugated Aptamer-Dicer Substrate RNAi Therapeutics
20 Jul 2009 Alnylam and Cubist Announce Complete Data from Phase II Study of ALN-RSV01 in Lung Transplant Patients Naturally Infected with Respiratory Syncytial Virus
17 Jul 2009 Alnylam Announces Extension of RNAi Therapeutics Collaboration with Novartis
13 Jul 2009 Oxford Biomedica Announces Update On Phase I/II Study Of ProSavin® In Parkinson's Disease
10 Jul 2009 Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
09 Jul 2009 Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
02 Jul 2009 Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
24 Jun 2009 Osiris Therapeutics Reports Interim Data for COPD Stem Cell Study
24 Jun 2009 Living Cell Technologies’ Diabetes Clinical Trial Authorized by New Zealand Government
24 Jun 2009 Mesoblast Limited's (ASX:MSB) First Patients In Bone Marrow Transplant Trial Show Earlier Engraftment
22 Jun 2009 Targeted Genetics Announces Continued Clinical Study at University College London/Moorfields Eye Hospital for a Gene Therapeutic to Treat Leber's Congenital Amaurosis and Provides Business Update
18 Jun 2009 FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial
18 Jun 2009 Glybera(TM) Shows Long-Term Health Benefits
18 Jun 2009 Alnylam and Collaborators Present New Pre-Clinical Research Findings on RNAi Therapeutics Targeting PCSK9, a Genetically Validated Regulator of LDL Metabolism

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top